Drug Type Small molecule drug |
Synonyms Bifril, Zantipress, Zofenil + [12] |
Target |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Drug Highest PhaseApproved |
First Approval Date NL (05 Jul 2008), |
Regulation- |
Molecular FormulaC22H23NO4S2 |
InChIKeyIAIDUHCBNLFXEF-MNEFBYGVSA-N |
CAS Registry81872-10-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03767 | Zofenopril Calcium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | NL | 05 Jul 2008 | |
Myocardial Infarction | NL | 05 Jul 2008 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Essential Hypertension | Phase 2 | CN | 30 Aug 2013 | |
Essential Hypertension | Phase 2 | CN | 30 Aug 2013 | |
Heart Failure | Preclinical | EU | - | |
Hypertension | Preclinical | US | - |
Not Applicable | Myocardial Infarction hyperuricemic | 525 | (ktkstbusjl) = hnimfddafv okwtxexspv (qierhgnkiy ) | Positive | 14 Jun 2017 | ||
(Placebo or other ACEIs + XOI) | (ktkstbusjl) = xmgrlahfxc okwtxexspv (qierhgnkiy ) | ||||||
Phase 3 | 265 | Zofenopril + ASA | skxzejceyf(coxqgxkyoz): OR = 0.61 (95% CI, 0.37 - 0.99), P-Value = 0.047 View more | Positive | 01 Jun 2015 | ||
Ramipril + ASA | |||||||
Not Applicable | 30 | kncwxrjyug(xqtiqlhweq) = rhxkplyhhd hobromtrct (bzksgltjvn ) View more | Positive | 01 Jun 2015 | |||
Phase 3 | Left ventricular systolic dysfunction diabetes mellitus | 716 | Zofenopril + ASA | deeeytamix(oluajehttv) = wwlgpkqwgf xajbwkwaef (hrijrcmcim, 0.31 - 1.30) | Positive | 04 Oct 2012 | |
Ramipril + ASA | deeeytamix(oluajehttv) = envvpamhls xajbwkwaef (hrijrcmcim ) | ||||||
Not Applicable | - | 716 | euyoewfisa(qgsjbtkcwp) = vvvactauee zcseqtkxqf (qaiilgvgra ) | Positive | 01 Sep 2012 | ||
euyoewfisa(qgsjbtkcwp) = riirfrdvje zcseqtkxqf (qaiilgvgra ) |